Group One Trading, L.P. Acurx Pharmaceuticals, Inc. Transaction History
Group One Trading, L.P.
- $3.01 Billion
- Q2 2024
A detailed history of Group One Trading, L.P. transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 5,222 shares of ACXP stock, worth $9,765. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,222
Previous 13,481
61.26%
Holding current value
$9,765
Previous $33,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ACXP
# of Institutions
29Shares Held
1.21MCall Options Held
14.3KPut Options Held
18.3K-
Vanguard Group Inc Valley Forge, PA492KShares$919,4540.0% of portfolio
-
Prospect Financial Services LLC Melville, NY295KShares$551,7900.35% of portfolio
-
Geode Capital Management, LLC Boston, MA130KShares$243,1280.0% of portfolio
-
Lpl Financial LLC Fort Mill, SC53.7KShares$100,4840.0% of portfolio
-
Morgan Stanley New York, NY46.4KShares$86,7690.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $21.6M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...